FLT4, human recombinant protein
Vascular endothelial growth factor receptor 3, Fms-like tyrosine kinase 4, Tyrosine-protein kinase r
|Calculated MW||120 kDa|
|Other Names||Vascular endothelial growth factor receptor 3, Fms-like tyrosine kinase 4, Tyrosine-protein kinase receptor FLT4|
|Application Notes||Reconstitute in sterile water to a concentration not less than 0.1 mg/ml. This solution can then be stored at 4°C for 2-7 days. For future use for future use; For long term storage it is recommended to add a carrier protein (0.1 % HSA or BSA) then store at –20°C. Avoid freeze-thaw cycles.|
|Storage||-20°C; Sterile filtered and lyophilized with no additives|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The Flt-4 gene is widely expressed in the early embryo but becomes restricted to the lymphatic endothelial a latter stages of development. It is important for lymphangiogenesis. Both VEGF family members VEGF-C and VEGF-D have been shown to bind and activate VEGFR-3/FLT-4. Soluble FLT4 Human Recombinant fused with a carboxy-terminal 6X histidine-tag produced in baculovirus is a monomeric, glycosylated, polypeptide containing the extracellular part, 25-774 amino acids and having a total molecular mass of 120 kDa. The soluble receptor protein contains only the first 7 extracellular domains, which contain all the information necessary for ligand binding.The FLT4 is purified by proprietary chromatographic techniques.
Pajusola K.,et al.Cancer Res. 52:5738-5743(1992).
Pajusola K.,et al.Cancer Res. 53:3845-3845(1993).
Galland F.,et al.Genomics 13:475-478(1992).
Galland F.,et al.Oncogene 8:1233-1240(1993).
Lee J.,et al.Proc. Natl. Acad. Sci. U.S.A. 93:1988-1992(1996).
If you have any additional inquiries please email technical services at firstname.lastname@example.org.